Effect of bone marrow mesenchymal stem cells transfected with rAAV2-bFGF on early angiogenesis of calvarial defects in rats

Meiling Chen , Ke Song , Nianjing Rao , Mengqi Huang , Zhengjiang Huang , Yingguang Cao

Current Medical Science ›› 2010, Vol. 30 ›› Issue (4) : 519 -524.

PDF
Current Medical Science ›› 2010, Vol. 30 ›› Issue (4) : 519 -524. DOI: 10.1007/s11596-010-0561-1
Article

Effect of bone marrow mesenchymal stem cells transfected with rAAV2-bFGF on early angiogenesis of calvarial defects in rats

Author information +
History +
PDF

Abstract

The purpose of this study was to evaluate the effect of bone marrow mesenchymal stem cells (MSCs) transfected with the basic fibroblast growth factor (bFGF)-expressing recombinant adeno-associated virus vector (rAAV2-bFGF), on early angiogenesis of calvarial defects in rats. The MSCs were cultured and transfected with rAAV2-bFGF after differential adherence isolation. The transfection efficiency was detected by RT-PCR and Western blotting. The transfected MSCs were compounded with poly-DL-lactide/hydroxyapatite (PDLLA/HA) in vitro. The cranial defect models in 36 male SD rats were created. Nothing (group A), PDLLA/HA alone (group B), PDLLA/HA combined with MSCs (group C), and PDLLA/HA combined with rAAV2-bFGF transfected MSCs (group D) were implanted in rat calvarial defects. The specimens were harvested for hematoxylin-eosin staining on the day 1, 3 and 7 after implantation. Factor VIII immunohistochemical staining and histomorphometric analysis were carried out to evaluate neovascularization around the implantation. The results indicated that MSCs could indeed be successfully transfected with the rAAV2-bFGF vector. Histological and histomorphometric analysis revealed that the angiogenesis in group D was significantly enhanced as compared with the rest groups (P<0.05). These results strongly suggest that MSCs transfected with rAAV2-bFGF in combination with PDLLA/HA can effectively promote the early angiogenesis of calvarial defects in rats, which played an important role in creating an environment suitable for the survival and activity of transplanted cells for further applications in cranio-maxillofacial bone regeneration.

Keywords

basic fibroblast growth factor / gene therapy / angiogenesis / bone regeneration

Cite this article

Download citation ▾
Meiling Chen, Ke Song, Nianjing Rao, Mengqi Huang, Zhengjiang Huang, Yingguang Cao. Effect of bone marrow mesenchymal stem cells transfected with rAAV2-bFGF on early angiogenesis of calvarial defects in rats. Current Medical Science, 2010, 30(4): 519-524 DOI:10.1007/s11596-010-0561-1

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

SakakibaraY., TambaraK., SakaguchiG., et al.. Toward surgical angiogenesis using slow-released basic fibroblast growth factor. Cardiothorac Surg, 2003, 24(1): 105-111

[2]

TabataY., HijikataS., IkadaY.. Enhanced vascularization and tissue granulation by basic fibroblast growth factor impregnated in gelatin hydrogels. J Control Release, 1994, 31(2): 189-199

[3]

OharaN., KoyamaH., MiyataT., et al.. Adenovirus-mediated ex vivo gene transfer of basic fibroblast growth factor promotes collateral development in a rabbit model of hind limb ischemia. Gene Ther, 2001, 8(11): 837-845

[4]

ColtonC.K.. Implantable biohybrid artificial organs. Cell Transplant, 1995, 4(4): 415-436

[5]

PolveriniP.J.. The pathophysiology of angiogenesis. Crit Rev Oral Biol Med, 1995, 6(3): 230-247

[6]

NussenbaumB., KrebsbachP.H.. The role of gene therapy for craniofacial and dental tissue engineering. Adv Drug Deliv Rev, 2006, 58(4): 577-591

[7]

StenderS., MurphyM., O’BrienT., et al.. Adeno-associated viral vector transduction of human mesenchymal stem cells. Eur Cell Mater, 2007, 13: 93-99

[8]

GuoX., ZhengQ., KulbatskiI., et al.. Bone regeneration with active angiogenesis by basic fibroblast growth factor gene transfected mesenchymal stem cells seeded on porous beta-TCP ceramic scaffolds. Biomed Mater, 2006, 1(3): 93-99

[9]

HiraideA., YokooN., XinK.Q., et al.. Repair of articular cartilage defect by intraarticular administration of basic fibroblast growth factor gene, using adeno-associated virus vector. Hum Gene Ther, 2005, 16(12): 1413-1421

[10]

GospodarowiczN., FerraraL., SchweigererL., et al.. Structural characterization and biological functions of fibroblast growth factor. Endocr Rev, 1987, 8(2): 95-114

[11]

HosseinkhaniH., HosseinkhaniM., KhademhosseiniA., et al.. Enhanced angiogenesis through controlled release of basic fibroblast growth factor from peptide amphiphile for tissue regeneration. Biomaterials, 2006, 27(34): 5836-5844

[12]

RenJ., ZhaoP., RenT., et al.. Poly (D,L-lactide)/nano-hydroxyapatite composite scaffolds for bone tissue engineering and biocompatibility evaluation. J Mater Sci Mater Med, 2008, 19(3): 1075-1082

[13]

MurphyW.L., SimmonsC.A., KaiglerD., et al.. Bone regeneration via a mineral substrate and induced angiogenesis. J Dent Res, 2004, 83(3): 204-210

[14]

TuliS.S., LiuR., ChenC., et al.. Immunohistochemical localization of EGF, TGF-α, TGF-β, and their receptors in rat corneas during healing of excimer laser ablation. Curr Eye Res, 2006, 31(9): 709-719

[15]

PetersenW., PufeT., StärkeC., et al.. Locally applied angiogenic factors—a new therapeutic tool for meniscal repair. Ann Anat, 2005, 187(5–6): 509-519

AI Summary AI Mindmap
PDF

104

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/